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Abstract
A diﬀerentiation method of human bone marrow mesenchymal stem cells (MSCs) to chondrocytes was
developed for the construction of a three-dimensional (3D) cartilage tissue. The adhesive cells, which were
isolated from a human bone marrow aspirate were embedded in type I collagen in a poly-L-lactate-glycolic
acid copolymer (PLGA) mesh and cultivated for 4 week together with growth factors. The degree of
cellular diﬀerentiation was estimated by quantitative RT-PCR of aggrecan and type II collagen mRNAs
and by staining with Safranin O. The 3D culture showed a higher degree of diﬀerentiation even without
growth factors than the conventional pellet culture with growth factors, namely, dexamethasone and
transforming growth factor (TGF)-b 3. The 3D culture for 2 week with the combined addition of dexa-
methasone, TGF-b 3, and insulin-like growth factor (IGF)-I reached a 30% expression of aggrecan mRNA
compared with that in primary human chondrocytes, while the aggrecan mRNA expression in the con-
ventional pellet culture was less than 2%. The sequential two-step diﬀerentiation cultivation, during which
the cells were cultivated in 3D for 1 week after the conventional two-dimensional (2D) culture for 1 week,
could markedly accelerate the expression of aggrecan mRNA compared with the 3D cultivation for 2 week.
Introduction
Mesenchymal stem cells (MSCs) in adult bone
marrow have been shown to give rise to multiple
mesodermal tissue types, including bone and
cartilage (Caplan 1991), tendon (Caplan et al.
1993), muscle (Wakitani et al. 1995), fat (Dennis
and Caplan 1996), and marrow stromal cells
(Majumdar et al. 1995). MSCs have an adher-
ent, ﬁbroblast-like morphology, and have surface
antigens characterized as CD45, which is a rep-
resentative marker of hematopoietic cells, and
CD105+, which is the TGF-b receptor endoglin
(Barry et al. 1999; Pittenger et al. 1999). These
stem cells are isolated from bone marrow aspirates
and present exciting opportunities for cell-based
therapeutic applications because of their multilin-
eage potential. In fact, therapeutic modalities have
been described for the use of MSCs in cartilage
Wakitani et al. 1994), bone (Bruder et al. 1998),
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tendon (Young et al. 1998), and bone marrow
stroma (Lazarus and Caplan 1995) regeneration.
The expansion of MSCs after isolation from
bone marrow is necessary for their application to
regenerative medicine, because the number of
MSCs in bone marrow aspirate is very small (e.g.,
2000 cells/ml (Bruder et al. 1997)). It has been
reported that human bone marrow mesenchymal
stem cells could be passaged in medium containing
fetal calf serum (FCS) up to the 38th population
doubling level (PDL) while still maintaining their
osteogenic potential (Bruder et al. 1997).
The diﬀerentiation of MSCs to chondrocytes by
the pellet cultivation method employing medium
with growth factors, namely, transforming growth
factor (TGF)-b 3 and dexamethasone, has been
reported (Alastair et al. 1998). Other growth fac-
tors such as TGF-b 1, bone morphogenic protein
(BMP)-2, and insulin-like growth factor (IGF)-1
have also been reported to be eﬀective on the dif-
ferentiation (Allison et al. 2000; Allison et al.
2001; Manas et al. 2001). The degree of diﬀeren-
tiation was estimated in these reports by dot-blot
analysis of aggrecan and type II collagen mRNA
expression and by staining with Safranin O and
alucian blue. However, there have been few reports
on the quantitative estimation of the diﬀerentia-
tion of MSCs to chondrocytes.
The size of the pellet (less than 1 mm) is very
small compared with the size of the cartilage tissue
(more than 5 mm in radius) required for regener-
ative medicine. That could be the reason why
several kinds of three-dimensional (3D) cultivation
methods, such as the gel-embedded cultures and
porous carrier cultures of primary chondrocytes,
have been studied. However, because of gel
shrinkage, it is diﬃcult to obtain a uniform cell
distribution in porous carriers such as sponge and
mesh. We previously developed a novel 3D culture
method for chondrocytes to obtain uniform cell
distribution and to eliminate the shrinkage by the
combination of collagen gel and poly-L-lactate-
glycolic acid copolymer (PLGA) mesh (Takagi
et al. 2004). Moreover, no report on the diﬀeren-
tiation of MSCs to chondrocytes in 3D culture has
been published, except for that employing gelatin
sponge (Ponticiello et al. 2000).
For the construction of 3D cartilage tissue, the
diﬀerentiation of MSCs to chondrocytes and 3D
tissue formation were considered as a one-set
process, and the optimization of diﬀerentiation
degree was investigated quantitatively in this
study.
Materials and methods
Cell preparation and culture methods
Bone marrow aspirate obtained by routine iliac
crest aspiration from human donors (age: 65–73)
was diluted with growth medium, plated in a dish
(55 cm2, Corning, Tokyo) to a concentration of
6.0 · 105 nucleated cells/cm2 and cultured at 37 C
in a humidiﬁed atmosphere containing 5% CO2,
during which the medium was changed on days 1,
2, 9 and 16. On day 19, the cells were detached
using trypsin-EDTA (Sigma, St. Louis, MO,
USA), counted by the trypan blue dye-exclusion
method and subcultivated at an initial cell density
of 1 · 104 cells/cm2. When the culture reached near
conﬂuence, the cells were harvested and employed
for further diﬀerentiation culture. The content of
CD105+ CD45 cells among the cells analyzed by
ﬂowcytometer was approximately 90% (data not
shown) (Takagi et al. 2003).
Media
The growth medium was DMEM-LG (Gibco, NY,
USA) supplemented with 10% FCS (Gibco),
2500 U/l penicillin, and 2.5 mg/l streptomycin.
The basal diﬀerentiation medium was DMEM-
HG (Gibco) supplemented with 10%FCS, 2500 U/
l penicillin, 2.5 mg/l streptomycin, 50 lg/ml
L-ascorbic acid 2-phosphate (Wako Pure Chemi-
cals, Osaka), 100 lg/ml sodium pyruvate (Wako),
and 40 lg/ml proline (Wako). Growth factors,
namely, 10 ng/ml transforming growth factor-b 3
(TGF-b 3, Peprotech), 39 ng/ml dexamethasone
(ICN Biomedicals), and 100 ng/ml insulin-like
growth factor-I (IGF-I, Peprotech), were added.
The gelling medium consisted of 30.5 g/l
DMEM-HG, 35.7% FCS, 8930 U/l penicillin,
8.93 mg/l streptomycin, and 179 lg/ml L-ascorbic
acid 2-phosphate.
Pellet cultivation
High-density pellet cell culture was initiated by
centrifugation (500 · g for 5 min) of 5 · 105 cells
suspended in 0.5 ml of the diﬀerentiation medium
12
in 15-ml conical tubes. The pellet was incubated
for 2–4 week at 37 C in 5% CO2, during which
the medium was changed weekly.
Two-dimensional (2D) diﬀerentiation cultivation
Cells were cultured on a dish (55 cm2, Corning,
Tokyo) at a density of 2.0 · 104 cells/cm2, which
corresponded to full conﬂuence, employing the
growth medium and then allowing the cells to
attach for 6 h at 37 C in 5% CO2. Then, the
medium was replaced with the diﬀerentiation
medium and cells were cultivated for 1 week.
Three-dimensional (3D) diﬀerentiation cultivation
Eight pieces of PLGA mesh (6 mm /, 0.25 mm
thickness, Vicryl Mesh 910TM, Johnson & Johnson,
Tokyo, Japan) were laid in a 96 multi-well plate for
suspension culture (Sumiron, Osaka, Japan). The
cell suspension (3.57 · 107 cells/ml) in gelling
medium was mixed with 2.57 aliquot volume of
type I collagen (0.5%, pH 3, Kokencellgen I-PCTM,
Koken, Tokyo, Japan) employing a vortex mixer in
ice bath. After the cell mixture in collagen (65 ll)
was poured into the 96 multi-well plate and incu-
bated at 37 C for 30 min, the diﬀerentiation
medium (260 ll) was added and the gel was incu-
bated for 24 h at 37 C in 5% CO2. Then, the gel
was transferred into a 24 multi-well plate and then
incubated for 4 week at 37 C in 5% CO2 together
with 1.8 ml of diﬀerentiation medium, during
which the medium was changed weekly.
Cell number analysis
The pellet was hydrolyzed at 37 C for 40 min
with a mixture of 5 g/l trypsin (Sigma), 5 g/l type
II collagenase (Worthington Biochemistry), and
5 g/l type I collagenase (Wako, Osaka, Japan).
The collagen gel culture was hydrolyzed at 37 C
for 3 h using 2.5 g/l collagenase. Then, the cell
concentration was determined by the trypan blue
method.
Staining
The pellet and collagen-gel cultures were rinsed
twice with PBS, ﬁxed in 20% formalin, dehydrated
through a graded series of ethanol, inﬁltrated with
isoamyl alcohol, and embedded in paraﬃn. Sec-
tions of 3 lm thickness were cut through the
center of the pellets and gel, and were stained with
1% Safranin O in 1% sodium borate.
RNA preparation and RT-PCR
Total RNA was extracted from cells before and
after the pellet and the gel-cultures (n = 3) using
the RNeasy mini Kit (Qiagen, Australia, Victoria).
DNase-treated RNA was used to produce cDNA
using Omniscript and Sensiscript RT Kits (Qiagen)
and the Gene Amp PCR System 9700 (Applied
Biosystems, USA, Foster City). PCR was per-
formed with the cDNA using a HotStar Tag
Master Mix Kit (Qiagen) and ABI PRISM 7700
(Applied Biosystems) using actin as the standard
(NM 001101, Applied Biosystems). The sequences
of primers and probes are listed in Table 1. The
cDNA prepared with RNA isolated from primary
human chondrocytes from an articular cartilage
was also employed as a positive control for the
PCR analysis. The ratio of mRNA expression in
cultured cells to that in primary chondrocytes was
calculated as the degree of expression.
Results
Eﬀect of growth factors on the expression of agg-
recan mRNA in 2D culture
Two-dimensional diﬀerentiation cultures were
performed for 7 days employing diﬀerentiation
medium supplemented with several combinations
of growth factors, and the degree of expression of
aggrecan mRNA was determined (Figure 1). There
was almost no change in cell density during culture
(data not shown). The degrees of expression in










the cultures without the growth factors and with
TGF-b 3 plus IGF-I were less than 1.5% and
showed almost no increase during culture. On the
other hand, the addition of TGF-b 3 plus dexa-
methasone increased the expression during the
culture, which reached 6.3% on day 7. Moreover,
the combined addition of these three growth fac-
tors caused a rapid increase in the degree of
expression of aggrecan mRNA during culture,
reaching 23% on day 7. Prolonging the diﬀerenti-
ation culture in 2D to 2 week resulted in cell
detachment and death (data not shown).
Diﬀerentiation in 3D culture
Diﬀerentiation in 3D and pellet cultures were
examined for 4 week. Degrees of expression of
aggrecan and type II collagen mRNA in inoculum
cells were 0.047 and 0%, respectively. The degrees
of expression at 2 week are shown in Figure 2.
While the pellet culture with TGF-b 3 plus
dexamethasone showed only 0.15% aggrecan
mRNA expression, the 3D culture showed 3.3%
even without any growth factor. The addition of
TGF-b 3 and dexamethasone with or without
IGF-I to the 3D culture markedly increased the
degree of expression to 17 and 28%, respectively.
On the other hand, the degrees of expression of
type II collagen mRNA in the pellet and 3D
cultures without any growth factor were less
than 0.001%. The addition of TGF-b 3 and
dexamethasone with or without IGF-I to the 3D
culture markedly increased the degree of expres-
sion of type II collagen mRNA to 0.01 and
0.03%, respectively.
Sections of cultures at 4 week were stained with
Safranin O (Figure 3). Three-dimensional culture
at day 1 showed no staining. The center of the
pellet was not stained while the edge part of
the pellet was well stained. The staining of the
3D culture at 4 week cultivated with TGF-b 3
and dexamethasone with or without IGF-I was
apparently higher than that without any growth
factor.
Two-step diﬀerentiation culture
In order to accelerate the diﬀerentiation, the two-
step culture with diﬀerentiation medium was
studied, in which cells were cultivated for 1 week
Figure 1. Eﬀect of growth factors on the expression of aggre-
can mRNA in 2D culture. MSCs were cultivated on a dish for
1 week together with the growth factors TGF-b 3 (T), dexa-
methasone (D), and IGF-I (I), and the degree of expression of
aggrecan mRNA was determined at day 1 (closed bar), 4 (gray
bar), and 7 (open bar). Bar indicates the standard deviation.
Figure 2. Eﬀect of growth factors on diﬀerentiation in 3D
culture. Pellet and 3D cultures of MSCs were performed for
2 week employing the growth factors TGF-b 3 (T), dexameth-
asone (D), and IGF-I (I), and the degrees of expression of
aggrecan and type II collagen mRNAs were determined. The
degree of expression of inoculum MSCs were 0.047 and 0%,
respectively. Bar indicates the standard deviation.
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in 3D after the 2D culture for 1 week, and then
compared with the one-step 3D culture (Figure 4).
The degree of expression of aggrecan mRNA
gradually increased during 2 week of the 3D cul-
ture. On the other hand, the degree in 2D rapidly
increased and reached 23% at 1 week while the
degree in the 3D culture was only 8.5% at 1 week.
The high degree attained in the 2D culture was
well maintained during the 2nd-step 3D culture.
Although there was almost no expression of type
II collagen mRNA at 1 week in both 2D and 3D
cultures, the degree increased apparently during
2nd week. The degree of type II collagen mRNA
expression at 2 week in the 2nd-step 3D culture
was markedly higher than that in the one-step 3D
culture.
Discussion
The degree of expression of aggrecan mRNA was
low and did not increase during the 2D cultures
without or with TGF-b 3 and IGF-I (Figure 1).
On the other hand, the combinations of TGF-b 3
and dexamethasone with or without IGF-I
resulted in apparently higher expression of aggre-
can mRNA and their degrees increased in 1 week.
Because employing these three factors resulted in
the highest degree of expression, the combined
Figure 3. Microscopic observation of sections stained with Safranin O. Pellet and 3D cultures of MSCs were performed for 4 week
employing the growth factors TGF-b 3 (T), dexamethasone (D), and IGF-I (I), and the sections were stained with Safranin O.
Figure 4. Two-step diﬀerentiation cultivation. MSCs were cul-
tivated in the single 3D (s) or two-step 2D–3D (d) cultures
employing medium supplemented with TGF-b 3, dexametha-
sone, and IGF-I, and the degrees of expression of aggrecan
mRNA and type II collagen mRNA were determined. Bar
indicates the standard deviation.
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addition of TGF-b 3, dexamethasone, and IGF-I
was the best cocktail to stimulate the diﬀerentia-
tion of MSCs to chondrocytes in the 2D culture.
The degrees of expression of aggrecan and type
II collagen mRNAs in the 3D culture even without
any growth factor were markedly higher than
those in the pellet culture with TGF-b 3 and
dexamethasone (Figure 2). The combined addition
of TGF-b 3, dexamethasone, and IGF-I resulted in
the highest expression of both aggrecan and type
II collagen mRNAs. The intensity of Safranin O
staining of sections of 3D cultures corresponded
with the degrees of expression (Figure 3). Conse-
quently, it was proved that this 3D culture method
was better than the pellet culture from the view-
point of not only tissue size but also degree of
diﬀerentiation. The combination of TGF-b 3,
dexamethasone, and IGF-I was also the best
cocktail for the 3D diﬀerentiation culture.
It has been reported that the expression of type
II collagen mRNA occurs in the later phase com-
pared with that of aggrecan mRNA during the
diﬀerentiation of MSCs to chondrocytes (Frank
et al. 2001). This might be true also in our case,
because the degrees of expression of type II col-
lagen mRNA were markedly lower than those of
aggrecan mRNA at 1 (Figure 4) and 2 week
(Figures 2 and 4) of culture.
The darkness of Safranin O staining of pellet
was markedly higher than that of 3D culture even
with optimum combination of factors (Figure 3).
This might be partly due to the diﬀerence in cell
density between pellet (approx. 1 · 108 cells/ml
with pellet size (approx. 1 mm · 1 mm · 0.5 mm))
and 3D gel (approx. 1 · 107 cells/ml). So, increas-
ing the cell concentration in 3D culture may partly
solve this problem.
The non-stained area at the center of the pellet
was not observed in the 3D culture. This suggests
that cell necrosis due to the limitation of mass
transfer occurred not in the 3D culture but in the
pellet culture (Figure 3). This may be one of the
reasons why the 3D culture even without any
growth factor showed a higher degree of expression
than the pellet culture with TGF-b 3 and dexa-
methasone (Figure 2). Thus, it was considered that
the 2D culture may be better than the 3D culture
from the viewpoint of diﬀerentiation speed because
the mass transfer rate may be higher in the 2D
culture than in the 3D culture. This was supported
by the ﬁnding that the degree of expression of
aggrecan mRNA even at 1 week in the 2D
culture supplemented with TGF-b 3, dexametha-
sone, and IGF-I (23%, Figure 1) was almost the
same as the degree at 2 week in the 3D culture
(28%, Figure 2).
Therefore, the two-step diﬀerentiation culture
containing 2D and 3D cultures was experimentally
compared with the single-step 3D diﬀerentiation
culture (Figure 4). Aggrecan expression level at
1 week in 2D culture (Figure 4) was comparable to
that at 1 week in 2D in Figure 1. On the other
hand, the expression level not only at 1 week but
also at 2 week in 3D culture in Figure 4 was
apparently lower than the level at 2 week in 3D
culture in Figure 2. The diﬀerence in culture
duration may be one of the reasons for this dif-
ference in expression level. However, there may be
unknown operational factors aﬀecting the activity
of cells employed in each culture.
In Figure 4, the degree of aggrecan mRNA
expression in the 2D culture increased more rap-
idly within 1 week compared with that in the 3D
culture, and the high level of expression attained in
the 2D culture was maintained during the follow-
ing 3D culture for 1 week. The degree of aggrecan
mRNA expression at 2 week in the single-step 3D
culture was apparently lower than that at 1 week
in the 2D culture. Consequently, the time required
to reach a high degree of aggrecan mRNA
expression such as 20% was successfully reduced
by more than 1 week using the two-step diﬀeren-
tiation culture procedure. The 2D and 3D cultures
in the two-step culture were mainly for diﬀerenti-
ation and accumulation of aggrecan, respectively.
Conclusion
The MSCs from the bone marrow aspirate could
be diﬀerentiated to chondrocytes in 3D culture
containing collagen gel and PLGA mesh by
employing the growth factors TGF-b 3, dexa-
methasone, and IGF-I. The two-step diﬀerentia-
tion culture using 2D culture followed by 3D
culture could successfully reduce the time required
for the diﬀerentiation.
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